9-(环氧-2-甲基)-9H-咔唑 | 52131-82-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 9-(环氧-2-甲基)-9H-咔唑
• 中文别名: 9-环氧丙基咔唑；9-(环氧乙烷-2-基甲基)-9H-咔唑；9-(环氧乙烷-2-基甲基)咔唑；9-(2-环氧乙烷基甲基)咔唑
• 英文名称: 9-(oxiran-2-ylmethyl)-9H-carbazole
• 英文别名: N-(2,3-epoxypropyl)carbazole；9-(2,3-epoxypropyl)carbazole；9-(oxiran-2-ylmethyl)carbazole；N-epoxypropyl carbazole；9-(2-methyloxyethylene)-9H-carbazole
• CAS: 52131-82-5
• 化学式: C₁₅H₁₃NO
• mdl: MFCD00218388
• 分子量: 223.274
• InChiKey: VAJIZAPXBKMPRO-UHFFFAOYSA-N

物化性质

• 熔点：
  110 °C
• 沸点：
  409.7±27.0 °C(Predicted)
• 密度：
  1.25±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  17.5
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2933990090

SDS

Name:	9-(Oxiran-2-ylmethyl)-9H-carbazole 97% Material Safety Data Sheet
Synonym:
CAS:	52131-82-5

Section 1 - Chemical Product MSDS Name:9-(Oxiran-2-ylmethyl)-9H-carbazole 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
52131-82-5	9-(Oxiran-2-ylmethyl)-9H-carbazole	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 52131-82-5: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 110 - 112 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C15H13NO
Molecular Weight: 223

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, carbon dioxide, ammonia.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 52131-82-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
9-(Oxiran-2-ylmethyl)-9H-carbazole - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 52131-82-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 52131-82-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 52131-82-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  9-(环氧-2-甲基)-9H-咔唑 在 N-溴代丁二酰亚胺(NBS) 、 potassium carbonate 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 生成 1-(3,6-dibromo-9H-carbazol-9-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol
  参考文献：
  名称：

  Potential Antimicrobial Isopropanol-Conjugated Carbazole Azoles as Dual Targeting Inhibitors of Enterococcus faecalis

  摘要：

  A series of isopropanol-bridged carbazole azoles as potential antimicrobial agents were designed and synthesized from commercial carbazoles. Bioassay revealed that 3,6-dichlorocarbazolyl triazole 3f could effectively inhibit the growth of E. faecalis with minimal inhibitory concentration of 2 mu g/mL. The active molecule 3f showed lower propensity to trigger the development of resistance in bacteria than norfloxacin and exerted rapidly bactericidal ability. Compound 3f also exhibited low cytotoxicity to normal mammalian RAW264.7 cells. Further mechanism exploration indicated that conjugate 3f was membrane active against E. faecalis and could form 3f-DNA complex by intercalating into DNA of resistant E. faecalis, which might be responsible for its antimicrobial action. Molecular docking showed an efficient binding of triazole derivative 3f with DNA gyrase enzyme through noncovalent interactions.

  DOI：

  10.1021/acsmedchemlett.7b00514
• 作为产物：
  描述：

  1-Chlor-3-(carbazol-9-yl)-propan-2-ol 在 氢氧化钾 作用下， 以 丙酮 为溶剂， 生成 9-(环氧-2-甲基)-9H-咔唑
  参考文献：
  名称：

  具有咔唑环的二醇及其氮杂衍生物

  摘要：

  DOI：

  10.1515/hc.2006.12.3-4.201

文献信息

• Development of Small-Molecule Cryptochrome Stabilizer Derivatives as Modulators of the Circadian Clock
  作者：Jae Wook Lee、Tsuyoshi Hirota、Anupriya Kumar、Nam-Jung Kim、Stephan Irle、Steve A. Kay

  DOI：10.1002/cmdc.201500260

  日期：2015.9

  underpinnings of the circadian clock. We previously discovered a carbazole derivative, KL001 (N‐(3‐(9H‐carbazol‐9‐yl)‐2‐hydroxypropyl)‐N‐(furan‐2‐ylmethyl)methanesulfonamide), as a stabilizer of the clock protein cryptochrome (CRY). Herein we describe an extensive structure–activity relationship analysis of KL001 derivatives leading to the development of a highly active derivative: 2‐(9H‐carbazol‐9‐

  小分子探针在加深我们对生物钟的分子基础的理解中起着重要作用。我们先前发现了咔唑衍生物KL001（N-（3-（9 H-咔唑-9-基）-2-羟丙基）-N-（呋喃-2-基甲基）甲磺酰胺）作为时钟蛋白隐色染料的稳定剂（哭）。在这里，我们描述了导致高活性衍生物发展的KL001衍生物的广泛的结构-活性关系分析：2-（9 H-咔唑-9-yl）-N-（2-氯-6-氰基苯基）乙酰胺（KL044）。随后的3D-QSAR分析确定了KL001衍生物的关键特征，并提供了其与CRY相互作用的分子水平理解。富电子咔唑，酰胺/羟基连接基，磺酰基和吸电子腈部分有助于提高生物活性。与Ser394和His357的氢键相互作用以及与Trp290的更强的CH-π相互作用使KL044比KL001更好。KL044延长了昼夜节律周期，抑制了Per2活性，并在报告基因检测中稳定了CRY，其效力比KL001高约十倍。总之，KL044是一种功
• Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors
  作者：Guangcheng Wang、Jing Wang、Dianxiong He、Xin Li、Juan Li、Zhiyun Peng

  DOI：10.1016/j.bmcl.2016.04.071

  日期：2016.6

  A new series of 1,2,4-triazine derivatives bearing carbazole moiety 7a-7p were designed, synthesized, and evaluated for their α-glucosidase inhibitory activity. The majority of the screened compounds displayed potent α-glucosidase inhibitory activity, with IC50 values in the range of 4.27±0.07-47.75±0.25μM as compared to the standard drug acarbose. Among the series, compound 7k represented the most

  设计，合成了一系列新的带有咔唑部分7a-7p的1,2,4-三嗪衍生物，并评估了其对α-葡萄糖苷酶的抑制活性。与标准药物阿卡波糖相比，大多数被筛选的化合物显示出有效的α-葡萄糖苷酶抑制活性，IC50值在4.27±0.07-47.75±0.25μM范围内。在该系列中，化合物7k表现出最强的α-葡萄糖苷酶抑制活性，IC50值为4.27±0.07μM。动力学分析表明，化合物7k是一种非竞争性抑制剂，Ki为4.43μM。此外，通过分子对接证实了化合物7k与α-葡糖苷酶的结合相互作用。这项研究表明，这些带有咔唑部分的1,2,4-三嗪衍生物是一类新型的α-葡萄糖苷酶抑制剂。
• Carbazole-Containing Sulfonamides as Cryptochrome Modulators
  申请人：Reset Therapeutics, Inc.

  公开号：US20130303524A1

  公开（公告）日：2013-11-14

  The subject matter herein is directed to carbazole-containing sulfonamide derivatives and pharmaceutically acceptable salts or hydrates thereof of structural formula I wherein the variable R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, B, C, D, E, F, G, H, a, and b are accordingly described. Also provided are pharmaceutical compositions comprising the compounds of formula I to treat a Cry-mediated disease or disorder, such as diabetes, obesity, metabolic syndrome, Cushing's syndrome, and glaucoma.

  本文涉及含有咔唑基磺胺衍生物及其药用可接受盐或水合物的结构式I，其中变量R1、R2、R3、R4、R5、R6、R7、A、B、C、D、E、F、G、H、a和b分别描述。还提供了包含式I化合物的药物组合物，用于治疗Cry介导的疾病或紊乱，如糖尿病、肥胖症、代谢综合征、库欣综合征和青光眼。
• CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS
  申请人：ReSet Therapeutics, Inc.

  公开号：US20150284362A1

  公开（公告）日：2015-10-08

  The subject matter herein is directed to carbazole-containing amide, carbamate, and urea derivatives and pharmaceutically acceptable salts or hydrates thereof of structural formula I wherein the variable R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, D, E, G, J, L, M, Q, a, and b are accordingly described. Also provided are pharmaceutical compositions containing the compounds of formula I to treat a Cry-mediated disease or disorder, such as diabetes, complications associated with diabetes, Cushing's syndrome, NASH, NAFLD, asthma, and COPD.

  本文涉及含有咔唑基的酰胺、碳酸酯和脲衍生物，以及其结构式I中的药用可接受盐或水合物，其中变量R1、R2、R3、R4、R5、R6、R7、A、D、E、G、J、L、M、Q、a和b分别描述。还提供了含有式I化合物的药物组合物，用于治疗Cry介导的疾病或紊乱，如糖尿病、与糖尿病相关的并发症、库欣综合征、NASH、NAFLD、哮喘和COPD。
• Molecular construction of multitarget neuroprotectors 4.* Synthesis and biological activity of conjugates of carbazoles and tetrahydrocarbazoles
  作者：V. B. Sokolov、A. Yu. Aksinenko、T. V. Goreva、T. A. Epishina、L. G. Dubova、E. S. Dubrovskaya、S. G. Klochkov、P. N. Shevtsov、E. F. Shevtsova、S. O. Bachurin

  DOI：10.1007/s11172-016-1582-x

  日期：2016.9

  Unknown conjugates of carbazoles and tetrahydrocarbazoles were obtained by the alkylation of carbazoles and tetrahydrocarbazoles with 3,6-substituted 9-oxiranylmethylcarbazoles. The influence of synthesized 1-(9Н-carbazol-9-yl)-3-(1,2,3,4-tetrahydro-5Н-pyrido[4,3-b]-indol-5-yl)propan-2-ones on functional characteristics of brain mitochondria has been studied. The potential neuroprotective activity

  咔唑和四氢咔唑的未知共轭物是通过咔唑和四氢咔唑与 3,6-取代的 9-环氧乙烷基甲基咔唑的烷基化获得的。合成1-(9Н-咔唑-9-基)-3-(1,2,3,4-四氢-5Н-吡啶并[4,3-b]-吲哚-5-基)丙-2-的影响对脑线粒体功能特性的研究。已使用谷氨酸毒性模型证明了几种代表性缀合物的潜在神经保护活性。